Cellebrite director Brandon Van Buren reports 35,554 shares

Q: What does Brandon Van Buren report owning in Cellebrite (CLBT) on this Form 3?

Brandon Van Buren reports beneficial ownership of 35,554 Ordinary Shares of Cellebrite DI Ltd. This is an initial disclosure of his holdings as a company director, providing a baseline view of his equity stake.

Q: How many Cellebrite (CLBT) RSUs does Brandon Van Buren hold?

He holds 10,601 restricted share units (RSUs), each representing a contingent right to receive one Ordinary Share. These RSUs form part of his total reported ownership of 35,554 Ordinary Shares in Cellebrite DI Ltd.

Q: When were Brandon Van Buren’s Cellebrite (CLBT) RSUs granted and when do they vest?

The 10,601 RSUs were granted on September 17, 2025 and vest on September 17, 2026. Upon settlement after vesting, each RSU converts into one Ordinary Share of Cellebrite DI Ltd.

Q: Does this Cellebrite (CLBT) Form 3 show any recent insider buying or selling?

No specific purchase or sale is reported here; the filing primarily records existing holdings. It lists 35,554 Ordinary Shares, including 10,601 RSUs, as Brandon Van Buren’s beneficial ownership baseline as a director of Cellebrite DI Ltd.

Q: What does it mean that Cellebrite (CLBT) RSUs represent a contingent right to shares?

Each RSU gives Brandon Van Buren a contingent right to receive one Ordinary Share after vesting and settlement conditions are met. Until settlement, RSUs are promises of future shares rather than current, freely tradable stock.

Cellebrite DI Ltd. director Brandon Van Buren filed an initial Form 3 reporting his ownership in the company.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Brandon Van Buren filed an initial Form 3 reporting his ownership in the company. He reports beneficial ownership of 35,554 Ordinary Shares. This total includes 10,601 Ordinary Shares represented by restricted share units granted on September 17, 2025 that vest on September 17, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Van Buren Brandon

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	--	--	--

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") — 35,554 shares (Direct)

Footnotes (1)

F1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Brandon Van Buren report owning in Cellebrite (CLBT) on this Form 3?

Brandon Van Buren reports beneficial ownership of 35,554 Ordinary Shares of Cellebrite DI Ltd. This is an initial disclosure of his holdings as a company director, providing a baseline view of his equity stake.

How many Cellebrite (CLBT) RSUs does Brandon Van Buren hold?

He holds 10,601 restricted share units (RSUs), each representing a contingent right to receive one Ordinary Share. These RSUs form part of his total reported ownership of 35,554 Ordinary Shares in Cellebrite DI Ltd.

When were Brandon Van Buren’s Cellebrite (CLBT) RSUs granted and when do they vest?

The 10,601 RSUs were granted on September 17, 2025 and vest on September 17, 2026. Upon settlement after vesting, each RSU converts into one Ordinary Share of Cellebrite DI Ltd.

Does this Cellebrite (CLBT) Form 3 show any recent insider buying or selling?

No specific purchase or sale is reported here; the filing primarily records existing holdings. It lists 35,554 Ordinary Shares, including 10,601 RSUs, as Brandon Van Buren’s beneficial ownership baseline as a director of Cellebrite DI Ltd.

What does it mean that Cellebrite (CLBT) RSUs represent a contingent right to shares?

Each RSU gives Brandon Van Buren a contingent right to receive one Ordinary Share after vesting and settlement conditions are met. Until settlement, RSUs are promises of future shares rather than current, freely tradable stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 08:06 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Van Buren Brandon

(Last)

(First)

(Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA

4970602

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	35,554⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

	/s/ Brandon Van Buren	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR